5,422 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 5,422 companies in the field of Biotechnology on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Cancer, Tumor, Cell, Research, Drug, Patients, Disease .

Start-ups (510)

Early-stage companies (1,230)

Established companies (3,078)

The majority of these companies is located in the following countries.

United States (2,976)

Germany (231)

United Kingdom (230)

China (210)

Example Companies

Find companies in your area

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

President, Connective Tissue Oncology Society President-Elect, Musculoskeletal Tumor Society President-Elect, ABJS Co-Chair NCCN ST Sarcoma Cmte The University ...

Editor, various journals HCI Sarcoma Services Desmoid Tumor – What Is It? • Benign soft tissue tumor – Derived from mesenchymal (connective) tissue – Driven ...

Tumors Dermatofibrosarcoma Protuberans Fibrosarcoma Desmoid Tumor – Classification Tumor = mass (in this case from a neoplasm) Benign Malignant (does ...

anatomic locations • Wide spectrum of locally aggressive behavior Desmoid Tumor Two Clinical Entities 1. Sporadic 85% of desmoid cases More commonly occur ...

the general population Desmoid Tumor – Presentation Highly variable because of the highly variable nature of the tumor itself: – Size – Location – Rate ...

Rate of growth and/or infiltration Desmoid Tumor – Presentation • A Bump • Growth may be slow or rapid • Pain may occur, from local nerve compression or

Overview - Donate Tissue for Research - DTRF Patient Registry - DTRF Virtual Tumor Board - Newly-Diagnosed? - Sign Up for Updates - Annual Patient Meetings ...

Grant Awards - Apply for a Grant - Get Involved - Donate - Desmoid Tumor Awareness Month - Take Action - Raise Funds for a Cure - Spread Awareness ...

Overview - Donate Tissue for Research - DTRF Patient Registry - DTRF Virtual Tumor Board - Newly-Diagnosed? - Sign Up for Updates - Annual Patient Meetings ...

Grant Awards - Apply for a Grant - Get Involved - Donate - Desmoid Tumor Awareness Month - Take Action - Raise Funds for a Cure - Spread Awareness ...

learn from it. Using Genome-Scale CRISPR Screening to Create a Desmoid Tumor Dependency Map A new research project supported by the DTRF aims to enable ...

enable clinicians in the future to select the best therapies for each desmoid tumor patient. Recognizing the diversity of desmoid tumors in their biological

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

IMB-212 is a novel antibody-drug conjugate that is targeted at an undisclosed tumor antigen in the secretome of cancer cells. IMB-212 is based on ImmunoBiochem's ...

amplified in the tumor microenvironment and possessing unique tumor biology. This targeting approach overcomes the challenges of solid tumor heterogeneity ...

heterogeneity and tumor penetration by antibodies. IMB-212 carries a clinically-proven cytotoxic payload and is currently at the preclinical stage of development. ...

aimed at the innate immune system. IMB-213I is targeted at an undisclosed tumor antigen in the secretome of cancer cells. IMB-213I is based on ImmunoBiochem's ...

to target select secreted proteins amplified in the tumor microenvironment and possessing unique tumor biology. IMB-213I designed for the selective and efficacious ...

of its immunomodulatory payload to important immune cells within the tumor and tumor stroma, differentiating it from most other antibodies carrying immunomodulatory

IMB-212 is a novel antibody-drug conjugate that is targeted at an undisclosed tumor antigen in the secretome of cancer cells. IMB-212 is based on ImmunoBiochem's ...

amplified in the tumor microenvironment and possessing unique tumor biology. This targeting approach overcomes the challenges of solid tumor heterogeneity ...

heterogeneity and tumor penetration by antibodies. IMB-212 carries a clinically-proven cytotoxic payload and is currently at the preclinical stage of development. ...

aimed at the innate immune system. IMB-213I is targeted at an undisclosed tumor antigen in the secretome of cancer cells. IMB-213I is based on ImmunoBiochem's ...

to target select secreted proteins amplified in the tumor microenvironment and possessing unique tumor biology. IMB-213I designed for the selective and efficacious ...

of its immunomodulatory payload to important immune cells within the tumor and tumor stroma, differentiating it from most other antibodies carrying immunomodulatory

COARE Biotechnology

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Curr Pharmacol Rep. 2015 Aug Regulation of miRNAs by agents targeting the tumor stem cell ...

Radiation Injury. Oncotarget. 2015 Aug Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic ...

chronic liver diseases. Oncotarget. 2015 Jun Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. PLoS One. 2015 Feb ...

in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. Oncotarget. 2015 Feb DCLK1 is a broadly dysregulated target against ...

esophageal adenocarcinoma. Oncotarget Oct 2014 DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition. ...

doublecortin-like kinase 1. Cancer Letters 2014 Aug XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. The World Journal of Gastroenterology

development focus on killing the primary tumor. Our focus is on the critical interplay between elimination of the primary tumor and the later development of metastasis

Oncomatryx

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

ONCOMATRYX ONCOMATRYX pioneering stromal medicine - ABOUT - TARGETING TUMOR STROMA - LEADERSHIP - SCIENTIFIC ADVISORY BOARD - COLLABORATIONS - PUBLICATIONS ...

ADC OMTX703 - PIPELINE - DIAGNOSTICS - COL11A1 BIOMARKER - INVASIVE TUMOR DIAGNOSTICS -invaScan- - BLADDER CANCER DIAGNOSTICS -bladderScan- - COMPANION ...

- CAREERS - NEXT EVENT TARGETING TUMOR STROMA Our mission: To develop novel precision drugs targeting the tumor stroma We envision a new era when cancer ...

combinations of precision drugs. Both tumor epithelial cells and the tumor microenvironment will be targeted, to block tumor growth, metastasis, immune suppression ...

precision drugs that target not only the tumor epithelial cells, but also the tumor microenvironment, the tumor-associated stroma: A complex, heterogeneous ...

fibroblasts, endothelial and haematopoietic cells, which play a key role in tumor invasion, angiogenesis, metastasis, drug resistance and immune suppression

ONCOMATRYX ONCOMATRYX pioneering stromal medicine - ABOUT - TARGETING TUMOR STROMA - LEADERSHIP - SCIENTIFIC ADVISORY BOARD - COLLABORATIONS - PUBLICATIONS ...

ADC OMTX703 - PIPELINE - DIAGNOSTICS - COL11A1 BIOMARKER - INVASIVE TUMOR DIAGNOSTICS -invaScan- - BLADDER CANCER DIAGNOSTICS -bladderScan- - COMPANION ...

VIDEO - CONTACT - CAREERS - NEXT EVENT Tumor microenvironment: A cancer key player to be fired Tumor microenvironment: A cancer key player to be ...

be fired Novel precision drugs that target the tumor microenvironment are entering the battlefield against cancer. Recent advances in the prevention and ...

fight late and invasive stages of cancer. Targeting the epithelial tumor cells, the tumor itself, with novel and innovative drugs has rendered poor results ...

expressed in the epithelial tumor cells, but in the microenvironment that surounds the tumor. This peritumoral microenvironment, the tumor stroma, is a complex

Nanopep

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Full - Typography /Home/Index/index 预约CTC检测 CTC是什么? CTC 全称Circulating Tumor Cell 循环肿瘤细胞 循环肿瘤细胞CTC被证实在肿瘤早期就会入血,早期检测出CTC可以早预防、早诊断、早治疗。 CTC临床意义 (90%的死亡来自于复发转移) ...

A类先导专项子课题负责人等。 Close 采用肿瘤捕手专用CTC采血管 常规采血4ml 7个工作日 出具CTC检测报告并提供权威解读 “Tumor detection using magnetosome nanoparticles functionalized with a newly screened ...

on Amyloid Aggregation”-ACS nano “Peptide-based isolation of circulating tumor cells by magnetic nanoparticles”-Journal of Materials Chemistry B “Multiple ...

Chip “Microarray Based Screening of Peptide Nano Probes for HER2 Positive Tumor”-Analytical chemistry “Identifying EGFR-Expressed Cells and Detecting EGFR ...

of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer ...

Breast “Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy”-OncoImmunology

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.